The UK spent £2.5 billion on academic-led commercialisation. Result: 40% industry revenue vs Fraunhofer’s 70%, poor exports, minimal company creation. Commercial problems need commercial solutions.

Germany doesn’t have a monopoly on brilliant scientists. The secret to Fraunhofer’s success lies in something Australian policy makers consistently overlook: commercial discipline, not research relevance.